Philippe de Figueiredo Braga Colares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Philippe de Figueiredo Braga Colares has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Ronaldo Adib Kairalla
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
3 shared publications - Bruno Guedes Baldi
Divisao de Pneumologia, Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sâo Paulo, Sâo Paulo, Brazil
2 shared publications - Akissy Aline Uchiyama Nomura1 shared publication
- Alessandro Wasum Mariani
University of Sao Paulo, Sao Paulo, SP, Brazil
1 shared publication - Alexandre Franco Amaral
Pulmonary Division, Cardiopulmonary Department, Instituto Do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, Brazil
1 shared publication - Alfredo Nicodemos Cruz Santana
Escola Superior de Ciências da Saúde, Brasília, Brazil
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 22 (7) , e15993
Agranulocitose secundária à lamotrigina: um relato de caso
A lamotrigina é uma medicação anticonvulsivante indicada tanto para crises focais quanto generalizadas, para adultos e crianças a partir de 2 anos de idade, apesar de estudos demonstrarem segurança e eficácia de uso a partir de 1 mês de vida (Piña-Garza et al., 2008). É uma droga totalmente absorvida via enteral, metabolizada no fígado e excretada via renal, com meia vida de 12 a 62 horas em adultos. A lamotrigina age inativando canais de sódio voltagem-dependentes dos neurônios e bloqueando a liberação de disparos neuronais repetitivos, além de ter possível ação sináptica ao diminuir a síntese e liberação de aspartato e glutamato de neurônios excitatórios, e, dessa forma, inibir a gênese de convulsões (Mitra-Ghosh et al., 2020). Os principais efeitos adversos da medicação incluem rash cutâneo, que pode acometer até 10% dos pacientes nos primeiros 2 meses de tratamento, cardiológicos, pelo potencial arritmogênico e neurológicos, ao causar sonolência. Os relatos de acometimento hematológico são mais raros, e já incluem leucopenia, neutropenia, trombocitopenia e coagulação intravascular disseminada, que podem ser decorrentes da inibição da diidrofolato-redutase, toxicidade medular direta ou parte da síndrome de hipersensibilidade à droga (Johnston & Uetrecht, 2014). O objetivo deste relato de caso é descrever a ocorrência de agranulocitose decorrente do uso da medicação em uma paciente idosa, com rápida recuperação após a suspensão do medicamento. Também busca ampliar a divulgação de potenciais efeitos adversos que, apesar de raros, são potencialmente graves, de modo que o reconhecimento dessa condição seja mais precoce e o risco de desfechos desfavoráveis, minimizados.
- 30 April 2025
- Published by Brazilian Journals in Caderno Pedagógico
- Vol. 22 (7) , e15993
Open AccessAgranulocitose secundária à lamotrigina: um relato de caso
A lamotrigina é uma medicação anticonvulsivante indicada tanto para crises focais quanto generalizadas, para adultos e crianças a partir de 2 anos de idade, apesar de estudos demonstrarem segurança e eficácia de uso a partir de 1 mês de vida (Piña-Garza et al., 2008). É uma droga totalmente absorvida via enteral, metabolizada no fígado e excretada via renal, com meia vida de 12 a 62 horas em adultos. A lamotrigina age inativando canais de sódio voltagem-dependentes dos neurônios e bloqueando a liberação de disparos neuronais repetitivos, além de ter possível ação sináptica ao diminuir a síntese e liberação de aspartato e glutamato de neurônios excitatórios, e, dessa forma, inibir a gênese de convulsões (Mitra-Ghosh et al., 2020). Os principais efeitos adversos da medicação incluem rash cutâneo, que pode acometer até 10% dos pacientes nos primeiros 2 meses de tratamento, cardiológicos, pelo potencial arritmogênico e neurológicos, ao causar sonolência. Os relatos de acometimento hematológico são mais raros, e já incluem leucopenia, neutropenia, trombocitopenia e coagulação intravascular disseminada, que podem ser decorrentes da inibição da diidrofolato-redutase, toxicidade medular direta ou parte da síndrome de hipersensibilidade à droga (Johnston & Uetrecht, 2014). O objetivo deste relato de caso é descrever a ocorrência de agranulocitose decorrente do uso da medicação em uma paciente idosa, com rápida recuperação após a suspensão do medicamento. Também busca ampliar a divulgação de potenciais efeitos adversos que, apesar de raros, são potencialmente graves, de modo que o reconhecimento dessa condição seja mais precoce e o risco de desfechos desfavoráveis, minimizados.
- Open Access
- 1 October 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (10) , 749-763
ANXIETY, DEPRESSION, AND QUALITY OF LIFE OF NURSES WORKING IN PUBLIC HOSPITALS
Nursing is often described as the art of caring, providing holistic patient assistance without time restrictions. However, due to this nature of work, it is common for these professionals to present symptoms of mental illnesses such as anxiety and depression. This results in a reduction in the quality of life at work, directly affecting the efficiency of care provision. This study aimed to verify the presence of anxiety and depression symptoms, as well as the index of quality of life at work among nurses working in the inpatient sector of public hospitals in the city of Aracaju. Among the 128 professionals included in the sample, 46.1% presented anxiety symptoms and 30.5% depression symptoms, according to the HADS scale. Additionally, 66.4% of nurses reported an unsatisfactory quality of life at work index (QLWI). The majority of professionals who presented symptoms of both diseases were female; 17.2% had two employment bonds, and 19.5% reported an unsatisfactory QLWI. Therefore, it is possible to infer that the accumulation of employment bonds and the reduction in quality of life at work may have been determining factors for the development of these symptoms. It is concluded that it is extremely important to improve working conditions, safety, and remuneration, as well as increase the institutional appreciation and recognition of nursing professionals. This would contribute to raising the quality of life indices at work and reducing the need for multiple employment bonds.
- 1 October 2024
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 6 (10) , 749-763
Open AccessANXIETY, DEPRESSION, AND QUALITY OF LIFE OF NURSES WORKING IN PUBLIC HOSPITALS
Nursing is often described as the art of caring, providing holistic patient assistance without time restrictions. However, due to this nature of work, it is common for these professionals to present symptoms of mental illnesses such as anxiety and depression. This results in a reduction in the quality of life at work, directly affecting the efficiency of care provision. This study aimed to verify the presence of anxiety and depression symptoms, as well as the index of quality of life at work among nurses working in the inpatient sector of public hospitals in the city of Aracaju. Among the 128 professionals included in the sample, 46.1% presented anxiety symptoms and 30.5% depression symptoms, according to the HADS scale. Additionally, 66.4% of nurses reported an unsatisfactory quality of life at work index (QLWI). The majority of professionals who presented symptoms of both diseases were female; 17.2% had two employment bonds, and 19.5% reported an unsatisfactory QLWI. Therefore, it is possible to infer that the accumulation of employment bonds and the reduction in quality of life at work may have been determining factors for the development of these symptoms. It is concluded that it is extremely important to improve working conditions, safety, and remuneration, as well as increase the institutional appreciation and recognition of nursing professionals. This would contribute to raising the quality of life indices at work and reducing the need for multiple employment bonds.
- Open Access
- 18 September 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (4) , e20230395
Thoracic ultrasound: a review of the state-of-the-art
Thoracic ultrasound (TUS) is a tool that has become increasingly essential in the daily practice of thoracic medicine. Driven by the need to assess patients during the COVID-19 pandemic, there has been an increase in the use of point-of-care TUS, which has demonstrated several benefits, either as a complement to clinical decision-making for diagnosis or as a real-time guide for procedures, whether as a predictor or measure of treatment response. Here, we present a review of TUS, based on the most recent scientific evidence, from equipment and techniques to the fundamentals of pulmonary ultrasound, describing normal and pathological findings, as well as focusing on the management of lung disease and guidance for invasive thoracic procedures at the bedside. Finally, we highlight areas of perspective and potential lines of research to maintain interest in this valuable tool, in order to improve the diagnostic process and expand the treatment arsenal.
- 18 September 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (4) , e20230395
Open AccessThoracic ultrasound: a review of the state-of-the-art
Thoracic ultrasound (TUS) is a tool that has become increasingly essential in the daily practice of thoracic medicine. Driven by the need to assess patients during the COVID-19 pandemic, there has been an increase in the use of point-of-care TUS, which has demonstrated several benefits, either as a complement to clinical decision-making for diagnosis or as a real-time guide for procedures, whether as a predictor or measure of treatment response. Here, we present a review of TUS, based on the most recent scientific evidence, from equipment and techniques to the fundamentals of pulmonary ultrasound, describing normal and pathological findings, as well as focusing on the management of lung disease and guidance for invasive thoracic procedures at the bedside. Finally, we highlight areas of perspective and potential lines of research to maintain interest in this valuable tool, in order to improve the diagnostic process and expand the treatment arsenal.
- Open Access
- 23 July 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (3) , e20240047
Respiratory amyloidosis: a case series from a Brazilian referral center
- 23 July 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (3) , e20240047
Open AccessRespiratory amyloidosis: a case series from a Brazilian referral center
- Open Access
- 20 June 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20230085
Idiopathic pulmonary fibrosis: current diagnosis and treatment
Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease without a clear recognizable cause. IPF has been at the forefront of new diagnostic algorithms and treatment developments that led to a shift in patients' care in the past decade, indeed influencing the management of fibrotic interstitial lung diseases other than IPF itself. Clinical presentation, pathophysiology, and diagnostic criteria are briefly addressed in this review article. Additionally, evidence regarding the use of antifibrotics beyond the settings of clinical trials, impact of comorbidities, and therapeutic approaches other than pharmacological treatments are discussed in further detail.
- 20 June 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20230085
Open AccessIdiopathic pulmonary fibrosis: current diagnosis and treatment
Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease without a clear recognizable cause. IPF has been at the forefront of new diagnostic algorithms and treatment developments that led to a shift in patients' care in the past decade, indeed influencing the management of fibrotic interstitial lung diseases other than IPF itself. Clinical presentation, pathophysiology, and diagnostic criteria are briefly addressed in this review article. Additionally, evidence regarding the use of antifibrotics beyond the settings of clinical trials, impact of comorbidities, and therapeutic approaches other than pharmacological treatments are discussed in further detail.
- Open Access
- 17 December 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (1) , e20220330
COVID-19 and pulmonary alveolar proteinosis: an unusual combination
- 17 December 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (1) , e20220330
Open AccessCOVID-19 and pulmonary alveolar proteinosis: an unusual combination
- Open Access
- 9 November 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (6) , e20220232
Tuberculous empyema: combined intrapleural therapy might be an alternative
- 9 November 2022
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 48 (6) , e20220232
Open AccessTuberculous empyema: combined intrapleural therapy might be an alternative
- 6 May 2022
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 65 (7) , 620-623
Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm that originates from hyperplasia and metaplasia of the mesothelial cells that cover the pleural cavity. Previous exposure to asbestos is the main risk factor. Since MPM is often diagnosed at an advanced stage with rapid evolution and resistance to treatment, it is associated with an unfavorable outcome. Mesothelioma in situ (MIS) has been postulated as a preinvasive phase of MPM; however, its diagnostic criteria have been defined only recently. Diagnosis of MIS may represent an opportunity for early therapies with better results, but the optimal approach has not been defined thus far. Here, we report on a case of a 74‐year‐old man with right‐sided pleural effusion and a previous history of occupational exposure to asbestos for 9 years who was diagnosed with MIS after a latency of 36 years. During follow‐up, spontaneous disease regression was observed 5 months after the initial diagnosis; however, it recurred in the form of invasive epithelioid MPM. There is a paucity of literature on MIS and its evolution; however, our case provides relevant knowledge of this unusual behavior, which is important to define follow‐up and therapeutic strategies for future cases.
- 6 May 2022
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 65 (7) , 620-623
Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm that originates from hyperplasia and metaplasia of the mesothelial cells that cover the pleural cavity. Previous exposure to asbestos is the main risk factor. Since MPM is often diagnosed at an advanced stage with rapid evolution and resistance to treatment, it is associated with an unfavorable outcome. Mesothelioma in situ (MIS) has been postulated as a preinvasive phase of MPM; however, its diagnostic criteria have been defined only recently. Diagnosis of MIS may represent an opportunity for early therapies with better results, but the optimal approach has not been defined thus far. Here, we report on a case of a 74‐year‐old man with right‐sided pleural effusion and a previous history of occupational exposure to asbestos for 9 years who was diagnosed with MIS after a latency of 36 years. During follow‐up, spontaneous disease regression was observed 5 months after the initial diagnosis; however, it recurred in the form of invasive epithelioid MPM. There is a paucity of literature on MIS and its evolution; however, our case provides relevant knowledge of this unusual behavior, which is important to define follow‐up and therapeutic strategies for future cases.
- Open Access
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 45 (5) , e20180343
An unusual cause of pleural effusion in a patient with heart failure
- 1 January 2019
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 45 (5) , e20180343
Open AccessAn unusual cause of pleural effusion in a patient with heart failure